# An Efficacy and Safety Study of Subcutaneous Anakinra in Chinese Patients With Systemic Juvenile Idiopathic Arthritis (SJIA) and Adult-Onset Still's Disease (AOSD)

> **NCT07706868** · PHASE4 · WITHDRAWN · sponsor: **Swedish Orphan Biovitrum**

## Conditions studied

- Systemic Juvenile Idiopathic Arthritis (sJIA)
- Adult Onset Still's Disease (AOSD)

## Interventions

- **DRUG:** Anakinra (Kineret®)

## Key facts

- **NCT ID:** NCT07706868
- **Lead sponsor:** Swedish Orphan Biovitrum
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-09-01
- **Primary completion:** 2028-09-30
- **Final completion:** 2028-09-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Business decision
- **Last updated:** 2026-07-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07706868

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07706868, "An Efficacy and Safety Study of Subcutaneous Anakinra in Chinese Patients With Systemic Juvenile Idiopathic Arthritis (SJIA) and Adult-Onset Still's Disease (AOSD)". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07706868. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*